FDA Inspection 1084048 — Zhejiang Dingtai Pharmaceutical Co., Ltd
The FDA completed an inspection of Zhejiang Dingtai Pharmaceutical Co., Ltd on Jan 25, 2019 in Jia Xing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 25, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jia Xing (China)